Panel Discussion | Cardiomyopathies

Saturday, March 7, 2026

3:27 PM - 3:45 PM EST

Location: Georgetown

Moderator(s)

Cynthia Bither, NP

NP, Advanced Heart Failure Program
MedStar Washington Hospital Center
Shady Side, Maryland, United States

Disclosure(s): No financial relationships to disclose
Nisha Gilotra, MD

Associate Professor of Medicine
Johns Hopkins University School of Medicine

Disclosure(s): No financial relationships to disclose
Mark R. Hofmeyer, MD, MS, FACC

Attending Physician - Advanced Heart Failure Associate Professor - Georgetown University School of Medicine
MedStar Health
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose
Daniele Massera, MD, MSc

Associate Director, Hypertrophic Cardiomyopathy Program
NYU Langone Health
New York, New York, United States

Disclosure(s): Chiesi Inc: Consulting Fees (e.g., advisory boards) (Terminated, April 30, 2025); Cytokinetics: Consulting Fees (e.g., advisory boards) (Terminated); Rocket Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Sanofi: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Panel Discussant(s)

Patrick T. Bering, MD

Cardiologist, Medical Director of Hypertrophic Cardiomyopathy
MedStar Washington Hospital Center
GLENELG, Maryland, United States

Disclosure(s): No financial relationships to disclose
Marat Fudim, MD

Associate Professor
Duke

Disclosure(s): Bayer HealthCare: Consulting Fees (e.g., advisory boards) (Ongoing)
Cyrus A. Hadadi, MD

Associate Director of Cardiac Arrhythmia Research
MedStar Heart & Vascular Institute
Washington, District of Columbia, United States

Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Marysa Leya, MD

Interventional Cardiologist
Northwestern Medicine

Disclosure(s): No financial relationships to disclose
Thomas E. MacGillivray, MD

Physician Executive Director and Chair, Cardiac Surgery
MedStar Health, MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose
Stephane Rinfret, MD, SM

Director of Complex Coronary Interventions
Georgia Heart Institute
Gainesville, Georgia, United States

Disclosure(s): SIS Medical: Consulting Fees (e.g., advisory boards) (Ongoing)
Maurice Sarano, MD

Senior Scientist
Minneapolis Heart Institute
Minneapolis, Minnesota, United States

Disclosure(s): HighLifeSAS: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Cynthia Bither, NP: No financial relationships to disclose

Nisha Gilotra, MD: No financial relationships to disclose

Mark R. Hofmeyer, MD, MS, FACC: No financial relationships to disclose

Daniele Massera, MD, MSc: Chiesi Inc: Consulting Fees (e.g., advisory boards) (Terminated, April 30, 2025); Cytokinetics: Consulting Fees (e.g., advisory boards) (Terminated); Rocket Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing); Sanofi: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Patrick T. Bering, MD: No financial relationships to disclose

Marat Fudim, MD: Bayer HealthCare: Consulting Fees (e.g., advisory boards) (Ongoing)

Cyrus A. Hadadi, MD: Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Marysa Leya, MD: No financial relationships to disclose

Thomas E. MacGillivray, MD: No financial relationships to disclose

Stephane Rinfret, MD, SM: SIS Medical: Consulting Fees (e.g., advisory boards) (Ongoing)

Maurice Sarano, MD: HighLifeSAS: Consulting Fees (e.g., advisory boards) (Ongoing)